887 related articles for article (PubMed ID: 21882140)
1. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
2. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
5. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
[TBL] [Abstract][Full Text] [Related]
7. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
8. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
Avital I; Brücher BL; Nissan A; Stojadinovic A
Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
11. Early intervention for treatment and prevention of colorectal carcinomatosis: a plan for individualized care.
Sugarbaker PH
Surg Oncol Clin N Am; 2012 Oct; 21(4):689-703. PubMed ID: 23021724
[TBL] [Abstract][Full Text] [Related]
12. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
Ceelen WP
Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
14. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
Elias D; Quenet F; Goéré D
Surg Oncol Clin N Am; 2012 Oct; 21(4):611-23. PubMed ID: 23021719
[TBL] [Abstract][Full Text] [Related]
15. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
[TBL] [Abstract][Full Text] [Related]
16. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
17. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
18. Surgery for colorectal peritoneal carcinomatosis.
Chua TC; Pelz JO; Morris DL
Scand J Gastroenterol; 2012 Mar; 47(3):277-85. PubMed ID: 22263634
[TBL] [Abstract][Full Text] [Related]
19. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
Di Carlo I; Pulvirenti E; Sparatore F; Toro A; Cordio S
Surg Oncol; 2007 Dec; 16 Suppl 1():S145-8. PubMed ID: 18023575
[TBL] [Abstract][Full Text] [Related]
20. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Iversen LH; Rasmussen PC; Laurberg S
Br J Surg; 2013 Jan; 100(2):285-92. PubMed ID: 23124619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
